MTOR and autosomal dominant polycystic kidney disease: Currently, it appears that research on the use of mTOR in ADPKD, despite a solid theoretical foundation and a proven mechanism of action, has not demonstrated sufficient effectiveness in limiting cyst growth and will not be continued because of the emergence of better therapeutic options.